Rt-PA versus streptokinase--Has the controversy regarding the optimal thrombolytic agent been resolved by results of the GISSI II/International rt-PA vs. Streptokinase fatality Study?
Gulba, D.C.; Lichtlen, P.R.
Zeitschrift für Kardiologie 80(1): 1-5
1991
ISSN/ISBN: 0300-5860 PMID: 2035282 Document Number: 383297
Document emailed within 1 workday
Related Documents
Tatu-Chiţoiu, G.; Teodorescu, C.; Dan, M.; Guran, M.; Căpraru, P.; Istrăţescu, O.; Tatu-Chiţoiu, A.; Bumbu, A.; Chioncel, V.; Arvanitopol, S.; Dorobanţu, M. 2004: Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. a substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA) Romanian Journal of Internal Medicine 42(3): 557-573Korol'chuk, V.I. 1999: Val709-Glu724 streptokinase binding site on plasminogen interacts with streptokinase sequence Thr361-Arg372 during plasminogen-streptokinase complex formation Ukrains'kyi Biokhimichnyi Zhurnal 71(4): 109-112
Levy, H.; Schoop, W.; Zeitler, E.; Schmidtke, I. 1972: 4-year experience in the thrombolytic therapy of chronic arterial occlusions. Early and late results in 350 patients treated with streptokinase Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 627-631
Reed, G.L.; Kussie, P.; Parhami-Seren, B. 1993: A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments Journal of Immunology 150(10): 4407-4415
Mafrici, A.; Mauri, F.; Maggioni, A.P.; Franzosi, M.G.; Santoro, L.; De Vita, C. 1995: Atenolol I.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. the GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico Giornale Italiano di Cardiologia 25(3): 353-364
Köhler, M.; Doenecke, P.; Hellstern, P.; Schwerdt, H.; Winter, R.; Ozbek, C.; Scheffler, P.; Knobloch, W.; von Blohm, G.; Keller, H.E. 1986: Thrombolytic therapy with ultra-high doses of streptokinase Folia Haematologica 113(1-2): 62-74
Strozzi, C.; Malin, L.; Cocco, G.; Longhini, C. 1977: Thrombolytic treatment of peripheral thromboembolic vascular diseases using streptokinase La Clinica Terapeutica 83(2): 135-150
Lew, A.S.; Laramee, P.; Cercek, B.; Rodriguez, L.; Ganz, W. 1985: Thrombolytic therapy with intracoronary or intravenous streptokinase during acute myocardial infarction Zeitschrift für Kardiologie 74(Suppl 6): 129-134
Assiri, A.S.; El-Gamal, B.A.; Hafez, E.E.; Haidara, M.A. 2014: Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy Saudi Medical Journal 35(12): 1482-1488
Kolb, G.; Funck, R.; Maisch, B.; Havemann, K. 1994: Paradoxic occurrence of symptoms of rheumatic fever after thrombolytic therapy with streptokinase--a case of delayed hypersensitivity? Zeitschrift für Rheumatologie 53(1): 7-10
Baraniková, D.; Renker, B.; Augustín, E.; Brunclík, P. 1993: Thrombolytic therapy of acute myocardial infarct in a district hospital. Analysis of a group of patients treated with streptokinase Vnitrni Lekarstvi 39(3): 260-265
Arnold, W.V.; Kirschbaum, M.J.; D'Alonzo, A.F.; Sallen, M.K.; Dickerson, W.H. 1986: Thrombolytic therapy in acute myocardial infarction utilizing high-dose, short-term intravenous streptokinase: report of a case and review of the literature Journal of the American Osteopathic Association 86(4): 243-247
Barbash, G.I.; White, H.D.; Modan, M.; Diaz, R.; Hampton, J.R.; Heikkila, J.; Kristinsson, A.; Moulopoulos, S.; Paolasso, E.A.; Van der Werf, T. 1995: Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial European Heart Journal 16(3): 313-316
Madsen, J.K.; Pedersen, F.; Amtoft, A.; Deding, A.; Grande, P.; Hansen, J.N.; Hilden, M.; Hornum, I.; Jensen, T.; Lindskov, J. 1989: Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2 Ugeskrift for Laeger 151(40): 2565-2569
Wiechowski, S.; Filipiak, K.; Brykczyński, M.; Listewnik, M.; Syberyjski, R. 1988: Results of the treatment of acute ischemia of the legs with small intra-arterial doses of streptokinase Polski Tygodnik Lekarski 43(34): 1088-1091
Binaghi, G.; Campolo, L.; Casari, A.; Repetto, S. 1987: The Italian Group for the Study of Streptokinase in Myocardial Infarct: Coronarographic and ventriculographic study Giornale Italiano di Cardiologia 17(1): 89-98
Zanolla, L.; Marino, P.; Golia, G.; Prioli, M.A.; Scazzina, L.; Moschini, E.; Bonmassari, R.; Zardini, P. 1987: The Italian Group for the Study of Streptokinase in Myocardial Infarct: Echocardiographic study Giornale Italiano di Cardiologia 17(1): 79-88
Beaufils, M.; Beaufils, H.; Lucsko, M.; Chapman, A.; Guédon, J. 1975: Late streptokinase therapy in thrombotic microangiopathy: a case study Clinical Nephrology 4(4): 160-163
Bell, W.R. 1976: Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study Thrombosis and Haemostasis 35(1): 57-69
Nikandrov, V.N.; Kaziuchits, O.A.; Iankovskaia, G.S. 1990: Study of the role of histidine residues in streptokinase molecule using modification with diethylpyrocarbonate Biokhimiia 55(5): 888-897